Search research articles
Contact Us
Filters
Showing results (11-20 of 89) with videos related to
Page
of 9
Sort By:
Acta Medica Scandinavica
|
January 1, 1981
Urinary beta-hexosaminidase excretion in polycystic kidney disease
P Swedenborg, B Hultberg, H Thysell
Scandinavian Journal of Urology and Nephrology
|
January 1, 1992
Erythropoietin treatment and plasma levels of corticotropin-releasing hormone, delta sleep-inducing peptide and opioid peptides in hemodialysis patients
J Hegbrant, H Thysell, R Ekman
The International Journal of Artificial Organs
|
July 1, 1991
Effects of recombinant human erythropoietin on the plasma levels of vasoactive regulatory peptides in patients on maintenance hemodialysis
J Hegbrant, H Thysell, R Ekman
Artificial Organs
|
February 1, 1997
Generation of nitrate during dialysis as a measure of nitric oxide synthesis
L Mårtensson, J Hegbrant, H Thysell
Annals of the Rheumatic Diseases
|
October 1, 1987
Alkylating cytostatic treatment in renal amyloidosis secondary to rheumatic disease
K Berglund, C Keller, H Thysell
Nephron
|
January 1, 1994
Effect of erythropoietin on muscle metabolic rate, as measured by direct microcalorimetry, and ATP in hemodialysis patients
B Fagher, H Thysell, M Monti
Scandinavian Journal of Haematology
|
March 1, 1981
Bone marrow morphology in patients in long-term treatment with azathioprine
U Sjögren, H Thysell, T Lindholm
American Journal of Nephrology
|
January 1, 1992
Serum levels of the soluble interleukin-2 receptor are dependent on the kidney function
L Nässberger, G Sturfelt, H Thysell
Human & Experimental Toxicology
|
August 1, 1994
Occurrence of autoantibodies directed against myeloperoxidase and elastase in patients treated with hydralazine and presenting with glomerulonephritis
O Torffvit, H Thysell, L Nässberger
Acta Psychiatrica Scandinavica
|
December 1, 1982
Urinary beta-hexosaminidase excretion in patients treated with lithium, thymoleptic and/or neuroleptic drugs
H Thysell, B Hultberg, G Regnell
Page
of 9
Search research articles
Search
Showing results (11-20 of 89) with videos related to
Sort By:
Page
of 9
Acta Medica Scandinavica
|
January 1, 1981
Urinary beta-hexosaminidase excretion in polycystic kidney disease
P Swedenborg, B Hultberg, H Thysell
Scandinavian Journal of Urology and Nephrology
|
January 1, 1992
Erythropoietin treatment and plasma levels of corticotropin-releasing hormone, delta sleep-inducing peptide and opioid peptides in hemodialysis patients
J Hegbrant, H Thysell, R Ekman
The International Journal of Artificial Organs
|
July 1, 1991
Effects of recombinant human erythropoietin on the plasma levels of vasoactive regulatory peptides in patients on maintenance hemodialysis
J Hegbrant, H Thysell, R Ekman
Artificial Organs
|
February 1, 1997
Generation of nitrate during dialysis as a measure of nitric oxide synthesis
L Mårtensson, J Hegbrant, H Thysell
Annals of the Rheumatic Diseases
|
October 1, 1987
Alkylating cytostatic treatment in renal amyloidosis secondary to rheumatic disease
K Berglund, C Keller, H Thysell
Nephron
|
January 1, 1994
Effect of erythropoietin on muscle metabolic rate, as measured by direct microcalorimetry, and ATP in hemodialysis patients
B Fagher, H Thysell, M Monti
Scandinavian Journal of Haematology
|
March 1, 1981
Bone marrow morphology in patients in long-term treatment with azathioprine
U Sjögren, H Thysell, T Lindholm
American Journal of Nephrology
|
January 1, 1992
Serum levels of the soluble interleukin-2 receptor are dependent on the kidney function
L Nässberger, G Sturfelt, H Thysell
Human & Experimental Toxicology
|
August 1, 1994
Occurrence of autoantibodies directed against myeloperoxidase and elastase in patients treated with hydralazine and presenting with glomerulonephritis
O Torffvit, H Thysell, L Nässberger
Acta Psychiatrica Scandinavica
|
December 1, 1982
Urinary beta-hexosaminidase excretion in patients treated with lithium, thymoleptic and/or neuroleptic drugs
H Thysell, B Hultberg, G Regnell
Page
of 9